FDA
approval
· 2021-05-12
FDA Approved: ZYNRELEF — Original Application (Heron Therapeutics, Inc.)
Summary
FDA approved ZYNRELEF, a fixed-dose combination of bupivacaine and meloxicam, for postoperative analgesia. The product combines a local anesthetic with an NSAID…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ZYNRELEF (BUPIVACAINE AND MELOXICAM)